Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
On the Structure and functions of gelatinase B/Matrix metalloproteinase-9 in neuroinflammation.
Different MOG35-55 concentrations induce distinguishable inflammation through early regulatory response by IL-10 and TGF-β in mice CNS despite unchanged clinical course.
A Case of Acute Disseminated Encephalomyelitis in a Middle-Aged Adult.
DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
Cell-Based Reparative Therapies for Multiple Sclerosis.
Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion.
Reply to Letter to Editor - Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma:Should it be termed paraneoplastic?
Hospital admission due to infections in multiple sclerosis patients.
[Progressive multifocal leukoencephalopathy as a complication of natalizumab therapy].
Adipose-Derived Stem Cells Promote Peripheral Nerve Regeneration In Vivo without Differentiation into Schwann-Like Lineage.
Artificial antigen presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4+ T cells.
Symptomatic treatment and management of multiple sclerosis.
Month of birth is not a definite risk factor for multiple sclerosis.
Alemtuzumab in the treatment of multiple sclerosis.
Pelvic floor disorders and multiple sclerosis: are patients satisfied with their care?
The Importance of Nitric Oxide and Arginase in the Pathogenesis of Acute Neuroinflammation: Are Those Contra Players with the Same Direction?
Incidence of the urological tumours in patients suffering from multiple sclerosis.
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy.
Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.
Epidemiological characteristics and functional disability of multiple sclerosis patients in kosovo.
Tissue structure and inflammatory processes shape viscoelastic properties of the mouse brain.
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination.
The development of primary central nervous system B-cell lymphoma in multiple sclerosis.
A proposed roadmap for inpatient neurology quality indicators.
Pages
« first
‹ previous
…
555
556
557
558
559
560
561
562
563
…
next ›
last »